Patients with metastatic colorectal cancer characteristics (n=21)
| n (%) median (min−max) (years) | |
| Patients | |
| Age at surgery | 68 (50–84) |
| Gender | |
| Male | 14 (67) |
| Female | 7 (33) |
| Primary cancer | |
| Location | |
| Colon | 13 (62) |
| Rectum | 8 (38) |
| Metastases | |
| Occurrence | |
| Synchronous | 19 (90) |
| Metachronous | 2 (10) |
| Neoadjuvant chemotherapy | |
| No | 4 (19) |
| Chemotherapy | 12 (57) |
| Chemotherapy+anti-VEGF | 5 (24) |
| RAS mutation | |
| No | 11 (52) |
| Yes | 9 (43) |
| Unknown | 1 (5) |
VEGF, vascular endothelial growth factor.